241 related articles for article (PubMed ID: 23994419)
21. Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the HeartMate II risk score.
Thomas SS; Nahumi N; Han J; Lippel M; Colombo P; Yuzefpolskaya M; Takayama H; Naka Y; Uriel N; Jorde UP
J Heart Lung Transplant; 2014 Jul; 33(7):675-81. PubMed ID: 24726424
[TBL] [Abstract][Full Text] [Related]
22. Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support.
Urban M; Pirk J; Szarszoi O; Besik J; Netuka I
Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):372-8. PubMed ID: 25487235
[TBL] [Abstract][Full Text] [Related]
23. Hemolysis in left ventricular assist device: a retrospective analysis of outcomes.
Ravichandran AK; Parker J; Novak E; Joseph SM; Schilling JD; Ewald GA; Silvestry S
J Heart Lung Transplant; 2014 Jan; 33(1):44-50. PubMed ID: 24418733
[TBL] [Abstract][Full Text] [Related]
24. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
[TBL] [Abstract][Full Text] [Related]
25. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
[TBL] [Abstract][Full Text] [Related]
26. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS)-defined morbidity and mortality associated with pediatric ventricular assist device support at a single US center: the Stanford experience.
Stein ML; Robbins R; Sabati AA; Reinhartz O; Chin C; Liu E; Bernstein D; Roth S; Wright G; Reitz B; Rosenthal D
Circ Heart Fail; 2010 Nov; 3(6):682-8. PubMed ID: 20807863
[TBL] [Abstract][Full Text] [Related]
27. Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: a Japanese multicenter study using J-MACS.
Saito S; Yamazaki K; Nishinaka T; Ichihara Y; Ono M; Kyo S; Nishimura T; Nakatani T; Toda K; Sawa Y; Tominaga R; Tanoue T; Saiki Y; Matsui Y; Takemura T; Niinami H; Matsumiya G;
J Heart Lung Transplant; 2014 Jun; 33(6):599-608. PubMed ID: 24746637
[TBL] [Abstract][Full Text] [Related]
28. Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump.
Goda M; Jacobs S; Rega F; Peerlinck K; Jacquemin M; Droogne W; Vanhaecke J; Van Cleemput J; Van den Bossche K; Meyns B
J Heart Lung Transplant; 2013 May; 32(5):539-45. PubMed ID: 23570742
[TBL] [Abstract][Full Text] [Related]
29. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
30. Outcomes in HeartMate II Patients With No Antiplatelet Therapy: 2-Year Results From the European TRACE Study.
Netuka I; Litzler PY; Berchtold-Herz M; Flecher E; Zimpfer D; Damme L; Sundareswaran KS; Farrar DJ; Schmitto JD;
Ann Thorac Surg; 2017 Apr; 103(4):1262-1268. PubMed ID: 27743637
[TBL] [Abstract][Full Text] [Related]
31. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
[TBL] [Abstract][Full Text] [Related]
32. Adverse neurologic events in patients bridged with long-term mechanical circulatory support: A device-specific comparative analysis.
Coffin ST; Haglund NA; Davis ME; Xu M; Dunlay SM; Cowger JA; Shah P; Aaronson KD; Pagani FD; Stulak JM; Maltais S;
J Heart Lung Transplant; 2015 Dec; 34(12):1578-85. PubMed ID: 26522376
[TBL] [Abstract][Full Text] [Related]
33. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
[TBL] [Abstract][Full Text] [Related]
34. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score.
Cowger J; Sundareswaran K; Rogers JG; Park SJ; Pagani FD; Bhat G; Jaski B; Farrar DJ; Slaughter MS
J Am Coll Cardiol; 2013 Jan; 61(3):313-21. PubMed ID: 23265328
[TBL] [Abstract][Full Text] [Related]
35. Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.
Hernandez RE; Singh SK; Hoang DT; Ali SW; Elayda MA; Mallidi HR; Frazier OH; Meyers DE
Tex Heart Inst J; 2015 Oct; 42(5):419-29. PubMed ID: 26504434
[TBL] [Abstract][Full Text] [Related]
36. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II).
Klovaite J; Gustafsson F; Mortensen SA; Sander K; Nielsen LB
J Am Coll Cardiol; 2009 Jun; 53(23):2162-7. PubMed ID: 19497443
[TBL] [Abstract][Full Text] [Related]
37. Non-cardiac surgery in patients on long-term left ventricular assist device support.
Morgan JA; Paone G; Nemeh HW; Henry SE; Gerlach B; Williams CT; Lanfear DE; Tita C; Brewer RJ
J Heart Lung Transplant; 2012 Jul; 31(7):757-63. PubMed ID: 22425233
[TBL] [Abstract][Full Text] [Related]
38. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
[TBL] [Abstract][Full Text] [Related]
39. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
[TBL] [Abstract][Full Text] [Related]
40. Clinical Outcome and Comparison of Three Different Left Ventricular Assist Devices in a High-Risk Cohort.
Zhigalov K; Mashhour A; Szczechowicz M; Mkalaluh S; Karagezian S; Gogia I; Isaev M; Kadyraliev BK; Easo J; Ennker J; Eichstaedt HC; Weymann A
Artif Organs; 2018 Nov; 42(11):1035-1042. PubMed ID: 29774558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
